Genomics Research Analysis Platform

NHSBT currently undertakes genetic testing for a variety of diagnostic purposes.

This includes the use of sequence-based typing methods (both NGS and Sanger sequencing) for approx.

120-150,000 tests/yr. and real time-PCR, PCR-SSP and PCR-SSO for approx.

200,000 tests/yr.

Since 2021 the Genomics programme has been initiating several subsidiary projects focussing on the use of two different types of technology.

Delivery of the Genomics programme is identified as a key driver within NHSBT's business plan, significantly contributing to 4 of the 5 strategic pillars: • Deliver Innovation • Grow and Diversify our Donor Base • Collaborate with Partners • Modernise our operations.

NHSBT is looking for one supplier to deliver the following aims: • Provide a cost effective, high throughput and flexible platform which will remediate the current pain points in data storage, sharing and interrogation; and allow NHSBT to conduct genotyping analysis more effectively to meet existing and future demand. • Deliver a specialist Platform as a Service (PaaS) solution for Genomics data storage, sharing and analysis.

At this stage NHSBT is looking for suppliers who may be interested in a potential future competition, demonstrating their potential solution or informing our business case.

Potential suppliers can respond to this RFI by completing the Response Section.

If this opportunity is not suitable for your organisation, there is no need to respond.

Suppliers who respond positively will be added to a mailing list and may be invited to a virtual information-gathering session with key stakeholders.

At any point suppliers are welcome to remove themselves from further communication at any point should they wish.